首页> 外文期刊>Radiology >Hepatic arterial and portal venous phase helical CT in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: added value of unenhanced images.
【24h】

Hepatic arterial and portal venous phase helical CT in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: added value of unenhanced images.

机译:经肝动脉化疗栓塞治疗肝细胞癌患者的肝动脉和门静脉期螺旋CT:未增强图像的附加价值。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To evaluate the additional diagnostic value of unenhanced computed tomographic (CT) images in the depiction of viable tumor in patients who were treated with transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) and followed up with biphasic helical CT that included the acquisition of unenhanced images. MATERIALS AND METHODS: We performed helical CT (with unenhanced, arterial, and portal phases) in 54 patients who had been treated with TACE for HCC. Image analysis was first performed with only those images obtained in the arterial and portal venous phases of helical CT. A second analysis was then performed with unenhanced images, arterial images, and portal venous images that focused on the additional value of unenhanced images. The value of additional unenhanced images was evaluated by means of interobserver agreement (kappa statistic) and receiver operating characteristic (ROC) analysis. RESULTS: The two readers detected 128 and 129 lesions. Unenhanced images were valuable for 32 of 129 lesions (23 patients) for reader 1 and for 29 of 128 lesions (21 patients) for reader 2. Although there was no significant difference between biphasic CT alone and biphasic CT with unenhanced images, results of ROC analysis showed higher diagnostic performance with biphasic CT with unenhanced images than with biphasic CT alone for detecting viable tumor. CONCLUSION: The study data demonstrate the diagnostic value of unenhanced images interpreted in conjunction with biphasic CT images for follow-up of patients who have previously been treated with TACE for HCC.
机译:目的:评价未增强的计算机断层扫描(CT)图像在肝癌(HCC)经导管动脉化疗栓塞(TACE)治疗并随后行双相螺旋CT扫描的患者中,在活体肿瘤描绘中的附加诊断价值。采集未增强的图像。材料与方法:我们对54例接受TACE治疗HCC的患者进行了螺旋CT(未增强,动脉和门静脉期)。首先仅对在螺旋CT的动脉和门静脉期获得的图像进行图像分析。然后对未增强图像,动脉图像和门静脉图像进行第二次分析,重点是未增强图像的附加价值。通过观察者之间的一致性(kappa统计量)和接收者操作特征(ROC)分析评估了其他未增强图像的价值。结果:两个阅读器检测到128和129病变。对于阅读器1,未增强的图像对于129个病灶中的32个(23例患者)和对于阅读器2对于128个病变(21个患者)中的29个,尽管单独的双相CT与未增强图像的双相CT之间没有显着差异,但ROC结果分析显示,在未增强图像的情况下,双相CT能够比单独的双相CT更好地诊断存活肿瘤。结论:研究数据表明,结合双相CT图像解释的未增强图像对先前接受过TACE治疗的HCC患者的随访具有诊断价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号